{"aid": "40291228", "title": "AstraZeneca withdrawing Covid vaccine worldwide, after finding rare side effect", "url": "https://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-to-withdraw-Covid-vaccine-worldwide-The-Telegraph-reports-46654465/", "domain": "marketscreener.com", "votes": 3, "user": "hammock", "posted_at": "2024-05-07 20:43:53", "comments": 0, "source_title": "AstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reports", "source_text": "AstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reports -\nMarketScreener\n\nOr log in with\n\nGoogleGoogle\n\nEmail Registration\n\nOr log in with\n\nGoogleGoogle\n\nEnglish (USA)\n\nEnglish (UK)\n\nEnglish (Canada)\n\nEnglish (India)\n\nDeutsch (Deutschland)\n\nDeutsch (\u00d6sterreich)\n\nDeutsch (Schweiz)\n\nEspa\u00f1ol\n\nFran\u00e7ais (France)\n\nFran\u00e7ais (Suisse)\n\nItaliano\n\nNederlands (Nederland)\n\nNederlands (Belgi\u00eb)\n\nIndexes Europe America Asia\n\nS&P 500\n\n5,188\n\n+0.13%\n\nDOW JONES\n\n38,884\n\n+0.08%\n\nNASDAQ 100\n\n18,091\n\n-0.01%\n\nRUSSELL 2000\n\n2,065\n\n+0.19%\n\nTSX COMP\n\n22,291\n\n+0.14%\n\nFTSE 100\n\n8,314\n\n+1.22%\n\nDAX\n\n18,430\n\n+1.40%\n\nCAC 40\n\n8,076\n\n+0.99%\n\nEURO STOXX 50\n\n5,016\n\n+1.19%\n\nMSCI CHINA\n\n60.23\n\n-0.82%\n\nTOPIX\n\n2,746\n\n+0.65%\n\nMSCI EMERGING\n\n1,068\n\n+0.10%\n\nMSCI WORLD\n\n3,399\n\n+0.25%\n\nSTOXX EU 600\n\n514\n\n+1.14%\n\nMSCI EUROPE\n\n172.3\n\n+1.15%\n\nDAX\n\n18,430\n\n+1.40%\n\nCAC 40\n\n8,076\n\n+0.99%\n\nFTSE 100\n\n8,314\n\n+1.22%\n\nBEL 20\n\n3,997\n\n+1.72%\n\nAEX\n\n900.1\n\n+1.00%\n\nSMI\n\n11,513\n\n+1.64%\n\nFTSE MIB\n\n34,242\n\n+0.75%\n\nIBEX 35\n\n11,081\n\n+1.50%\n\nOMX SWEDEN\n\n2,593\n\n+1.15%\n\nOMX NORDIC 40\n\n2,778\n\n+1.72%\n\nWIG INDEX (PLN)\n\n86,484\n\n-0.11%\n\nS&P 500\n\n5,188\n\n+0.13%\n\nDOW JONES\n\n38,884\n\n+0.08%\n\nNASDAQ 100\n\n18,091\n\n-0.01%\n\nNASDAQ CMP\n\n16,333\n\n-0.10%\n\nRUSSELL 2000\n\n2,065\n\n+0.19%\n\nTSX COMP\n\n22,291\n\n+0.14%\n\nMEXICO-IPC\n\n57,108\n\n-0.30%\n\nBOVESPA\n\n129,210\n\n+0.58%\n\nCOLOMBIA INDEX\n\n369.4\n\n+0.08%\n\nCHILE INDEX\n\n528.2\n\n+0.72%\n\nMSCI PERU\n\n9,270\n\n-0.57%\n\nMERVAL\n\n1,463,624\n\n-2.15%\n\nMSCI LATIN AM.\n\n2,504\n\n+0.28%\n\nTOPIX\n\n2,746\n\n+0.65%\n\nNIKKEI 225\n\n38,835\n\n+1.57%\n\nKOSPI CMP\n\n2,734\n\n+2.16%\n\nMSCI CHINA\n\n60.23\n\n-0.82%\n\nHANG SENG\n\n18,479\n\n-0.53%\n\nSHENZHEN A\n\n1,879\n\n+0.24%\n\nSHANGHAI A\n\n3,300\n\n+0.22%\n\nTWSE 50\n\n16,140\n\n+1.09%\n\nSET\n\n1,376\n\n+0.47%\n\nBSE SENSEX 30\n\n73,512\n\n-0.52%\n\nMSCI SINGAPORE\n\n6,243\n\n-0.16%\n\nSYDNEY ASX\n\n7,793\n\n+1.44%\n\nMSCI PACIFIC\n\n167.2\n\n+0.34%\n\nMore Indexes\n\nMy Watchlist\n\nINFINEON TECHNOLOGIES AG\n\n+12.93%\n\nUBS GROUP AG\n\n+7.59%\n\nUNICREDIT S.P.A.\n\n+3.59%\n\nNIPPON ACTIVE VALUE FUND PLC\n\n+0.58%\n\nAPPLE INC.\n\n+0.38%\n\nAMD (ADVANCED MICRO DEVICES)\n\n-0.87%\n\nBOEING\n\n-0.92%\n\nBP PLC\n\n-1.31%\n\nTESLA, INC.\n\n-3.76%\n\nWALT DISNEY COMPANY (THE)\n\n-9.51%\n\nMy lists\n\nRankings\n\nFMC CORPORATION\n\n+9.46%\n\nINTERNATIONAL FLAVORS & FRAGRANCES INC.\n\n+6.40%\n\nKENVUE INC.\n\n+6.36%\n\nFIDELITY NATIONAL INFORMATION SERVICES, INC.\n\n+5.48%\n\nGLOBE LIFE INC.\n\n+5.34%\n\nJACOBS SOLUTIONS INC.\n\n-4.99%\n\nILLUMINA, INC.\n\n-5.18%\n\nNRG ENERGY, INC\n\n-5.76%\n\nWALT DISNEY COMPANY (THE)\n\n-9.51%\n\nBUILDERS FIRSTSOURCE, INC.\n\n-19.05%\n\nLoading...\n\nMore Top / Flop\n\nRankings\n\nGLOBALFOUNDRIES, INC.\n\n+7.10%\n\nOLD DOMINION FREIGHT LINE, INC.\n\n+2.56%\n\nVERISK ANALYTICS, INC.\n\n+2.13%\n\nMERCADOLIBRE, INC.\n\n+2.11%\n\nGE HEALTHCARE TECHNOLOGIES INC.\n\n+2.04%\n\nTHE TRADE DESK, INC.\n\n-1.88%\n\nMONGODB, INC.\n\n-2.83%\n\nTESLA, INC.\n\n-3.76%\n\nILLUMINA, INC.\n\n-5.18%\n\nDATADOG, INC.\n\n-11.48%\n\nLoading...\n\nMore Top / Flop\n\nCurrency / Forex\n\nUSD / EUR\n\n0.9299\n\n+0.12%\n\nUSD / CAD\n\n1.372\n\n+0.40%\n\nUSD / MXN\n\n16.89\n\n+0.08%\n\nUSD / BRL\n\n5.074\n\n-0.04%\n\nUSD / INR\n\n83.44\n\n-0.01%\n\nUSD / CNY\n\n7.218\n\n+0.14%\n\nUSD / JPY\n\n154.6\n\n+0.20%\n\nUSD / AUD\n\n1.516\n\n+0.40%\n\nUSD / KRW\n\n1,359\n\n+0.40%\n\nUSD / HKD\n\n7.82\n\n+0.03%\n\nUSD / GBP\n\n0.7995\n\n+0.41%\n\nUSD / CHF\n\n0.9082\n\n+0.16%\n\nForex\n\nCommodities\n\nGOLD\n\n2,314\n\n-0.52%\n\nCRUDE OIL (WTI)\n\n78.15\n\n-0.66%\n\nCRUDE OIL (BRENT)\n\n82.89\n\n-0.78%\n\nSILVER\n\n27.23\n\n-0.77%\n\nPLATINUM\n\n977.5\n\n+2.02%\n\nCommodities\n\nCryptocurrencies\n\nBITCOIN\n\n62,835\n\n-0.53%\n\nETHEREUM\n\n3,039\n\n-0.79%\n\nRIPPLE\n\n0.5295\n\n-1.99%\n\nCryptocurrencies\n\nLog In\n\nNot a member ?\n\nEmail Registration\n\nOr log in with\n\nGoogleGoogle\n\nLog in\n\nSign up\n\n  * Homepage\n  * Markets\n\n    * Equities\n\n      * Top Capitalization\n      * United States\n      * North America\n      * Europe\n      * Asia\n      * Middle East\n      * Sector Research\n      * Earnings Calendar\n      * Equities Analysis\n      * Most popular\n      * BOEING\n      * UNICREDIT S.P.A.\n      * APPLE INC.\n      * INFINEON TECHNOLOGIES AG\n      * AMD (ADVANCED MICRO DEVICES)\n      * UBS GROUP AG\n      * NIPPON ACTIVE VALUE FUND PLC\n    * Indexes\n\n      * Homepage\n      * Rankings\n      * Europe\n      * America\n      * Asia\n      * Africa\n      * Index Analysis\n      * Indexes News\n      * S&P 500\n      * DOW JONES\n      * NASDAQ 100\n      * TSX COMP\n      * FTSE 100\n      * DAX\n      * CAC 40\n      * EURO STOXX 50\n    * Currency / Forex\n\n      * Homepage\n      * Rankings\n      * Currency Cross Rate\n      * Currency Converter\n      * Forex Analysis\n      * Currencies News\n      * USD / EUR\n      * USD / CAD\n      * USD / MXN\n      * USD / BRL\n      * USD / INR\n    * Commodities\n\n      * Homepage\n      * Energy\n      * Precious metals\n      * Agriculture\n      * Industrial Metals\n      * Livestock and Cattle\n      * GOLD\n      * CRUDE OIL (WTI)\n      * CRUDE OIL (BRENT)\n      * SILVER\n      * PLATINUM\n    * Cryptocurrencies\n\n      * Homepage\n      * Rankings\n      * Charts\n      * Analysis\n      * News\n      * BITCOIN\n      * ETHEREUM\n      * BINANCE COIN\n      * SOLANA\n      * CARDANO\n      * CHAINLINK\n    * Interest Rates\n\n      * Homepage\n      * Developed Nations\n      * Emerging Countries\n    * ETF\n\n      * Summary\n      * Screener\n      * Analysis\n      * News\n  * News\n\n    * All News\n\n      * World\n      * United States\n      * Europe\n      * North America\n      * South America\n      * Asia\n      * Africa\n      * Middle East\n      * Emerging\n    * Companies\n\n      * All News\n      * Analyst Reco.\n      * Rumors\n      * IPOs\n      * Capital Markets Transactions\n      * New Contracts\n      * Profit Warnings\n      * Appointments\n      * Press Releases\n      * Security Transactions\n      * Earnings reports\n      * New markets\n      * New products\n      * Corporate strategies\n      * Legal risks\n      * Share buybacks\n      * Mergers and acquisitions\n      * Call Transcripts\n      * Guidance\n    * Indexes\n    * Currency / Forex\n    * Commodities\n    * Cryptocurrencies\n    * ETF\n    * Interest Rates\n    * Economy\n    * Themes\n\n      * Asset Management\n      * Activism\n      * Climate and ESG\n      * Cybersecurity\n      * Geopolitics\n      * Central Banks\n      * Private Equity\n      * Inflation\n      * Business Leaders\n    * Sectors\n    * All our articles\n    * Most Read News\n    * Hot News\n  * Analysis\n\n    * All Analysis\n    * Must Read\n    * Equities\n    * Interviews\n    * Indexes\n    * Currencies\n    * Commodities\n    * ETF\n    * Cryptocurrencies\n    * Stock Trading Strategies\n\n      * All\n      * America\n      * Europe\n      * Asia\n  * Our Shows\n\n    * Shows\n    * Strategy\n    * Must Watch\n    * Satirical Cartoon\n    * Today's Editorial\n    * Crypto Recap\n    * Behind the numbers\n  * Stock Picks\n\n    * All our investments\n    * United States\n    * Europe\n    * Asia, Pacific\n  * Portfolios\n\n    * Virtual Portfolios\n    * USA Portfolio\n    * European Portfolio\n    * Asian Portfolio\n  * Watchlists\n\n    * My Watchlists\n\n      * Watchlists\n      * My previous session\n      * My most visited\n      * Most popular\n    * Investment Style\n\n      * Homepage\n      * Top ROE\n      * Growth stocks at reasonable prices\n      * Dividend Kings\n      * Small caps\n      * Undervalued stocks\n      * Quality stocks at a reasonable price\n    * Investment Themes\n\n      * Homepage\n      * Adtechs\n      * Outdoor\n      * Ageing Population\n      * REITS\n      * Blockchain\n      * The genomic revolution\n  * Rankings\n\n    * Top Movers\n\n      * Top Movers\n      * Unusual volumes\n      * New Historical Highs\n      * New Historical Lows\n      * Long Term\n    * Top Fundamentals\n\n      * Top Fundamentals\n      * Sales growth\n      * Earnings Growth\n      * Profitability\n      * Finances\n    * Rankings Valuation\n\n      * Rankings Valuation\n      * P/E ratio\n      * Enterprise value\n      * Yield\n    * Top Consensus\n\n      * Top Consensus\n      * Analyst Opinion\n      * Target price\n      * Estimates Revisions\n      * Divergence\n    * Top Technicals\n\n      * Top RSI\n      * GAPS\n      * STIM\n      * Breakouts\n      * Trends\n      * Volatility\n    * Top ranking ESG\n\n      * Top ranking ESG\n      * Environment\n      * Social\n      * Governance\n    * Visibility Ranking\n  * Screeners\n\n    * Stock Screener Home\n    * Investment Themes\n\n      * The food of tomorrow\n      * Moat\n      * Private Equity\n      * Strategic Metals\n      * The Internet of Things\n      * Israeli innovation\n    * Technical Rankings\n\n      * Oversold stocks\n      * Overbought stocks\n      * Close to resistance\n      * Close to support\n      * Accumulation Phases\n      * Most volatile stocks\n    * Fundamental Rankings\n\n      * Top Investor Rating\n      * Top Trading Rating\n      * Top Consensus\n      * Top Growth\n      * Top Dividends\n      * Low valuations\n    * My Screeners\n\n      * All my stocks\n      * Watchlists\n      * Virtual Portfolios\n  * Tools\n\n    * MarketScreener tools\n\n      * Stock Screener\n      * iPhone App\n    * Expert tools\n\n      * Stock Screener PRO\n      * Portfolio Creator\n      * Event Screener\n    * Dynamic Chart\n    * Earnings Calendar\n    * Economic Calendar\n    * Currency Converter\n  * Our Services\n\n    * Our subscriptions\n    * Our Stock Picks\n    * Stock Screener\n    * Thematic Investment Lists\n    * MarketScreener Portfolios\n\n      * European Portfolio\n      * USA Portfolio\n      * Asian Portfolio\n\nEnglish (USA)\n\nEnglish (UK)\n\nEnglish (Canada)\n\nEnglish (India)\n\nDeutsch (Deutschland)\n\nDeutsch (\u00d6sterreich)\n\nDeutsch (Schweiz)\n\nEspa\u00f1ol\n\nFran\u00e7ais (France)\n\nFran\u00e7ais (Suisse)\n\nItaliano\n\nNederlands (Nederland)\n\nNederlands (Belgi\u00eb)\n\nASTRAZENECA PLC\n\nAdd to a list\n\nTo use this feature you must be a member\n\nLog inSign up\n\n## AstraZeneca PLC\n\n## Equities\n\n## AZN\n\n## GB0009895292\n\n## Pharmaceuticals\n\nMarket Closed - London S.E.Other stock markets11:35:21 2024-05-07 am EDT|\n5-day change| 1st Jan Change  \n---|---|---  \n12,118 ^ GBX| +0.56%| +0.78%| +14.32%  \n  \n11:03pm| AstraZeneca to withdraw COVID-19 vaccine globally, Telegraph reports|\nRE  \n---|---|---  \n10:38pm| AstraZeneca to withdraw Covid vaccine worldwide, The Telegraph\nreports| RE  \n  \n# AstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reports\n\nMay 07, 2024 at 04:38 pm EDT\n\nShare\n\nMay 7 (Reuters) - Anglo-Swedish drugmaker AstraZeneca is withdrawing its Covid\nvaccine worldwide, The Telegraph reported on Tuesday.\n\nThe application to withdraw the vaccine was made on March 5 and came into\neffect on Tuesday, the report added. (Reporting by Urvi Dugar in Bengaluru;\nEditing by Pooja Desai)\n\nShare\n\n\u00a9 Reuters - 2024\n\n### Latest news about AstraZeneca PLC\n\nAstraZeneca to withdraw COVID-19 vaccine globally, Telegraph reports| 46 min\nago| RE  \n---|---|---  \nAstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reports| 1h\nago| RE  \nThe Oxford-Astrazeneca COVID Vaccine Is Being Withdrawn Worldwide- The\nTelegraph| 1h ago| RE  \nTHE OXFORD-ASTRAZENECA COVID VACCINE IS BEING WITHDRAWN WORL...| 1h ago| RE  \nBerenberg Raises AstraZeneca PT, Keeps Rating at Buy| 9h ago| MT  \nASTRAZENECA : Berenberg keeps its Buy rating| 12h ago| ZD  \nAstraZeneca target raised; Antofagasta lowered| 12h ago| AN  \nBP starts USD1.75 billion share buyback scheme| 14h ago| AN  \nCellectis: alliance with AstraZeneca finalized| May. 06| CF  \nCellectis Secures $140 Million Additional Equity Investment From AstraZeneca|\nMay. 06| MT  \nAstraZeneca: equity investment in Cellectis| May. 06| CF  \nAstraZeneca completes collaboration and investment deal with Cellectis| May.\n06| AN  \nAstraZeneca Secures 44% Stake in French Biotech Cellectis| May. 06| MT  \nAngle shares up on assay development deal with AstraZeneca| May. 03| AN  \nAngle shares up on assay development deal with AstraZenaca| May. 03| AN  \nAngle Plc to Supply Prostate Cancer Androgen Receptor Detection Assay to\nAstraZeneca| May. 03| MT  \nAIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal| May. 03|\nAN  \nConfident start before US jobs data| May. 03| AN  \nInterContinental Hotels makes first-quarter progress| May. 03| AN  \nAstraZeneca Says Calquence Combination Improves Progression-Free Survival in\nPhase 3 Mantle Cell Lymphoma Trial| May. 02| MT  \nAstraZeneca: research into respiratory diseases| May. 02| CF  \nAstraZeneca Announces Positive High-Level Results from an Interim Analysis of\nthe Echo Phase III Trial| May. 02| CI  \nAstraZeneca PLC Announces Positive High-Level Results from an Interim Analysis\nof the Echo Phase III Trial| May. 02| CI  \nAstraZeneca: encouraging results in lymphoma| May. 02| CF  \nAstraZeneca notes positive trial results for Calquence treatment| May. 02| AN  \n  \n### Chart AstraZeneca PLC\n\nMore charts\n\n## Company Profile\n\nAstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales\nbreak down by source of income as follows: - product sales (95.6%). Net sales\nbreak down by treatment area between oncology (39.2%), cardiovascular, renal\nand metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%),\nand other (22.7%; inflammatory diseases, neurological diseases,\ngastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net\nsales are distributed geographically as follows: the United Kingdom (7.4%),\nEurope (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).\n\nSector\n\nPharmaceuticals\n\nCalendar\n\n2024-05-19 - American Thoracic Society Conference - Abstarct Number - P297\n\nRelated indices\n\nSTOXX EUROPE 600 (EUR) , FTSE 100\n\nMore about the company\n\n### Income Statement Evolution\n\nMore financial data\n\n### Analysis / Opinion\n\nASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade\n\nApril 25, 2024 at 12:02 pm EDT\n\nMore Strategies\n\n### Ratings for AstraZeneca PLC\n\nTrading Rating\n\nInvestor Rating\n\nESG Refinitiv\n\nB+\n\nMore Ratings\n\n## Analysts' Consensus\n\nSell\n\nBuy\n\nMean consensus\n\nBUY\n\nNumber of Analysts\n\n22\n\nLast Close Price\n\n151.2 USD\n\nAverage target price\n\n165.3 USD\n\nSpread / Average Target\n\n+9.27%\n\nConsensus\n\n### EPS Revisions\n\nEstimates Revisions\n\n### Quarterly earnings - Rate of surprise\n\nCompany calendar\n\n### Sector Other Pharmaceuticals\n\n1st Jan change| Capi.  \n---|---  \nASTRAZENECA PLC| +14.32%| 235B  \nELI LILLY AND COMPANY| +33.43%| 690B  \nNOVO NORDISK A/S| +26.43%| 546B  \nJOHNSON & JOHNSON| -5.12%| 358B  \nMERCK & CO., INC.| +19.59%| 323B  \nABBVIE INC.| +4.89%| 287B  \nNOVARTIS AG| +5.79%| 199B  \nROCHE HOLDING AG| -9.49%| 195B  \nAMGEN INC.| +4.26%| 161B  \nPFIZER, INC.| -3.54%| 159B  \n  \nOther Pharmaceuticals\n\n  1. Stock Market\n\n  2. Equities\n\n  3. AZN Stock\n\n  4. News AstraZeneca PLC\n\n  5. AstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reports\n\nBest financial portal\n\n+951% of historical performance\n\nMore than 20 years at your side\n\n\\+ 950,000 members\n\nQuick & easy cancellation\n\nOur Experts are here for you\n\nOUR EXPERTS ARE HERE FOR YOU\n\nMonday - Friday 9am-12pm / 2pm-6pm GMT + 1\n\nContact us\n\nLegal information | Cookie settings | MarketScreener Blog | Copyright \u00a9 2024 Surperformance. All rights reserved.\n\nStock quotes are provided by Factset, Morningstar and S&P Capital IQ\n\n-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.\n\n12\n\n02\n\n10\n\n02\n\nSIGN UP NOW\n\n", "frontpage": true}
